Heart disease and antiretroviral therapy

Cardiovascular disease (disorders of the heart and circulatory system which can lead to heart attack and stroke) is the leading cause of death in the UK and the US. As many of the metabolic changes associated with HIV and antiretroviral therapy are also risk factors for heart disease, there has been concern about the long-term consequences of these changes.

Although one of the major studies of cardiovascular risk in HIV has concluded that “an epidemic of cardiovascular disease in HIV-positive people receiving protease inhibitor-based treatment is not on the horizon”, there has still been a significant rise in cardiovascular disease among people on HAART and each individual's risk requires careful assessment.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.